InsidersTradesSigma
Explore the complete record of transactions filed by Blanchard Cheryl R, Présidente et Directrice Générale. Insider active across 2 companies, notably Anika Therapeutics, Inc.. In total, 5 reports have been recorded. Total volume traded: €99k. The latest transaction was disclosed on 26 April 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
5 of 5 declarations
Cheryl R. Blanchard is President and CEO of Anika Therapeutics, Inc. She leads the strategic and operational activities of the company, focusing on innovation and product development. Her leadership is essential in achieving Anika's growth objectives.